IPSIS Urges Humana to Cover PNS

On March 18, 2024, IPSIS joined the Multisociety Pain Workgroup (MPW) in submitting a letter to Humana expressing concerns over its new Medicare Advantage policy that went into effect on January 1, 2024. This policy, which excludes coverage for peripheral nerve stimulators (PNS) used in the treatment of chronic pain, directly contradicts Medicare's established practice of covering such treatments.

The letter emphasizes the effectiveness of PNS in managing chronic pain, citing numerous clinical studies and systematic reviews supporting its safety and efficacy. These studies demonstrate the positive impact of PNS on various chronic pain conditions, including neuropathic cranial pain, post-amputation/stump pain, and chronic pelvic pain.

Help sustain this vital advocacy with your donations. The International Pain and Spine Intervention Society (IPSIS) is a tax-exempt organization under US section 501(c)(3) of the Internal Revenue Code. As such, contributions are deductible to the extent allowed by law